Skip to main content
. 2022 Nov 12;212(1):25–34. doi: 10.1007/s00430-022-00753-6

Table 2.

Seropositivity rates and neutralization antibody levels in 76 healthcare workers at 2, 4 and 6 months since onset of symptoms

Time of follow-up (months) Time of follow-upSARS-CoV-2 strain/variant Number of samples Non detectable n (%) Positive n (%) NAb titer 1:10–1:40 n (%) NAb titer 1:80–1:320 n (%) NAb titer ≥ 1:640 n (%) Median (IQR)a GMT value (95% CI)a
2 D614G 76 26 (34.2) 50 (65.8) 36 (47.4) 13 (17.1) 1 (1.3) 10.0 (5.0–40.0) 16.5 (12.6–21.7)
Delta 76 56 (73.7) 20 (26.3) 19 (25.0) 1 (1.3) 0 (0.0) 5.0 (5.0–10.0) 6.4 (5.7–7.2)
Gamma 76 61 (80.3) 15 (19.7) 15 (19.7) 0 (0.0) 0 (0.0) 5.0 (5.0–5.0) 5.9 (5.4–6.4)
Mu 76 70 (92.1) 6 (7.9) 6 (7.9) 0 (0.0) 0 (0.0) 5.0 (5.0–5.0) 5.3 (5.1–5.5)
Omicron 76 73 (96.0) 3 (4.0) 3 (4.0) 0 (0.0) 0 (0.0) 5.0 (5.0–5.0) 5.1 (5.0–5.3)
4 D614G 76 26 (34.2) 50 (65.8) 42 (55.3) 7 (9.2) 1 (1.3) 10.0 (5.0–40.0) 14.9 (11.4–19.5)
Delta 76 39 (51.3) 37 (48.7) 36 (47.4) 1 (1.3) 0 (0.0) 5.0 (5.0–10.0) 8.2 (7.1–9.5)
Gamma 76 51 (67.1) 25 (32.9) 25 (32.9) 0 (0.0) 0 (0.0) 5.0 (5.0–5.0) 6.5 (5.9–7.2)
Mu 76 61 (80.3) 15 (19.7) 15 (19.7) 0 (0.0) 0 (0.0) 5.0 (5.0–5.0) 5.7 (5.4–6.1)
Omicron 76 69 (90.8) 7 (9.2) 7 (9.2) 0 (0.0) 0 (0.0) 5.0 (5.0–5.0) 5.4 (5.1–5.7)
6 D614G 76 6 (7.9) 70 (92.1) 37 (48.7) 26 (34.2) 7 (9.2) 40.0 (20.0–160.0) 48.0 (34.0–67.8)
Delta 76 26 (34.2) 50 (65.8) 40 (52.6) 10 (13.2) 0 (0.0) 10.0 (5.0–20.0) 14.1 (10.9–18.3)
Gamma 76 36 (47.4) 40 (52.6) 39 (51.3) 1 (1.3) 0 (0.0) 10.0 (5.0–10.0) 8.3 (7.3–9.5)
Mu 76 42 (55.3) 34 (44.7) 34 (44.7) 0 (0.0) 0 (0.0) 5.0 (5.0–10.0) 7.5 (6.6–8.4)
Omicron 76 64 (84.2) 12 (15.8) 12 (15.8) 0 (0.0) 0 (0.0) 5.0 (5.0–5.0) 5.8 (5.3–6.5)

NAb Titer neutralizing antibodies titer

aNon detectable results were assigned a value of 5.0